Global Genetic Testing Market By Testing Type(Carrier Testing, Diagnostic Testing, New-born Screening, Predictive and Pre-Symptomatic Testing, Pharmacogenetics, Prenatal Testing, Preimplantation Testing, Others) By Sample Type(Blood, Buccal Swab, Amniocentesis, Chorionic Villus Sampling, Others) By Indication(Single Gene Disorders, Cardiovascular Diseases, Cancer Diagnosis(Colon Cancer, Breast Cancer, Ovarian Cancer, Others) Ophthalmology, Dermatology, Neurology, Immunology, Hematology, Pediatric Genetics, Metabolic disorders, Others) By Providers (Hospital, Specialty Clinics, Diagnostic Centers) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Recent breakthroughs in genetic technology have had a significant impact on medical genetics practise, both in the laboratory and in the clinic. Traditionally, genetic testing has been conducted and interpreted in the context of clinical or medical research. However, direct-to-consumer genetic testing (DTC-GT) has exploded in popularity over the last decade, allowing individuals to learn about their genetic profiles without having to go through a healthcare provider. Due to the rise in genetic disorders and high prelevance of cancer amongst a huge population, genetic testing is gaining popularity due to its reliable results. In pharmacogenomics, also known as drug-gene testing, for example, genetic testing has been frequently used. Moreover the advancements in genetic testing techniques such as the next generation sequencing technologies can detect even smaller parts of genes and DNA by breaking the entire genotype (or genome) into small segments and then analysing the DNA sequence of some or all of the segments for diagnosis. These testing techniques are contributing to an effective diagnosis for better treatments. Furthermore the leading players in the genetic testing market are focused on product advances and improvements in genetic testing platforms with increasing competition. In addition, prominent businesses are forming strategic alliances with companies that complement their product line in order to grow their worldwide presence through acquisitions and partnerships. For instance, Illumina Inc. signed a definitive deal to purchase GRAIL in September 2020 in order to extend its portfolio: breakthrough multi-cancer screening test (based on next-generation sequencing (NGS)).
In terms of revenue, global genetic testing market was valued at US$ 16,616.4 Mn in 2021 and is expected to reach US$ 42,323.1 Mn by 2020, growing at a CAGR of 10.9% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Genetic Testing Market Revenue & Forecast, (US$ Million), 2015 – 2030
Testing Type Outlook
Based on the testing type, the global genetic testing is segmented into carrier testing, diagnostic testing, new-born screening, predictive and pre-symptomatic testing, pharmacogenetics, prenatal testing, preimplantation testing and others. The newborn screening testing segment held a dominant position with highest revenue in 2021. This is due to a rise in public awareness about healthcare and an increase in the number of individuals dying from hereditary disorders around the world. On the other hand pharmacogenetics testing is gaining quite popularity as the tests look for changes or variants in the genes that may determine whether a medication could be an effective treatment for the patient or whether it could have side effects to a specific medication. Thus with the rise in demand for personalized medicine, the global genetic testing market is experiencing huge growth.
Sample Type Outlook
Based on sample type, the global genetic testing market is segmented into blood, buccal swab, amniocentesis, chorionic villus sampling and others. The blood segment dominated the market in 2021.The diagnosis of various diseases and infections have been predominantly carried out through blood test over a long period of time. Genetic blood tests are an important element of the diagnostic process because they help doctors make the right diagnosis and choose the right treatment. Moreover advanced technologies are being used for genetic testing through blood samples to detect various diseases in shorter span of time. For instance, during new born screening small amount of blood samples are collected to diagnose the presence of any diseases or abnormalities.
Indication Outlook
Based on the indication segment, the market is segmented into single gene disorders, cardiovascular diseases, cancer diagnosis (colon cancer, breast cancer, ovarian cancer, others) ophthalmology, dermatology, neurology, immunology, hematology, pediatric genetics, metabolic disorders and others. Paediatric genetics is anticipated to be the fastest growing segment in the global genetic testing market for the forecast period 2022-2030. Over the last decade there has been a significant rise in the awareness about hereditary diseases which has led to high demand for genetic testing. Paediatric genetics involves diagnoses, counselling with many different kinds of problems amongst children such as Down syndrome, Williams syndrome, achondroplasia or sickle cell disease. Moreover companies are looking forward in providing a through paediatric genetics testing and counselling through experienced paediatric genetic specialists for better treatments. Thus genetic testing market is expected to flourish in the upcoming years.
Region Outlook
Based on the regions, North America had the highest share in the genetic testing market in the year 2021. This is due to the presence of the majority of the region's significant players. However, due to increased healthcare spending, and increased awareness of genetic disorders the genetic testing market in North America is booming. Moreover the subsequent rise in the cases of chronic diseases and rising number of cancer patients have to led to an increased adoption of genetic testing in the last few years. Thus, these factors are leading to the growth of genetic testing market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global genetic testing market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global genetic testing market are:
- Abbott Laboratories
- Avellino Lab USA, Inc.
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- BioReference Laboratories
- CENTOGENE AG
- EONE LABORATORIES
- Eurofins
- F. Hoffmann-La Roche Ltd
- Genomic Health
- Invitae Corporation
- Laboratory Corporation of America Holdings
- MedGenome Labs Pvt. Ltd
- Myriad Genetics, Inc
- NeoGenomics Laboratories, Inc.
- QIAGEN
- Quest Diagnostics Incorporated
- UNILABS
- Other Market Participants
Global Genetic Testing Market:
By Testing Types
- Carrier Testing
- Diagnostic Testing
- New-born Screening
- Predictive and Pre-Symptomatic Testing
- Pharmacogenetics
- Prenatal Testing
- Preimplantation Testing
- Others
By Sample Type
- Blood
- Buccal Swab
- Amniocentesis
- Chorionic Villus Sampling
- Others
By Indication
- Single Gene Disorders
- Cardiovascular Diseases
- Cancer Diagnosis
- Colon Cancer
- Breast Cancer
- Ovarian Cancer
- Others
- Ophthalmology
- Dermatology
- Neurology
- Immunology
- Hematology
- Pediatric Genetics
- Metabolic disorders
- Others
By Providers
- Hospital
- Specialty Clinics
- Diagnostic Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 - 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Genetic Testing Market
6. Market Synopsis:
Genetic Testing Market
7. Genetic Testing Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Genetic Testing Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Genetic Testing Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Genetic Testing Market
8. Global Genetic Testing Market Analysis and Forecasts, 2022 -
2030
8.1. Overview
8.1.1. Global
Genetic Testing Market Revenue (US$ Mn)
8.2. Global
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
8.2.1. Carrier
Testing
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 - 2021
8.2.1.3. Market
Forecast, 2022 - 2030
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 - 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 - 2030
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 - 2030
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 - 2030
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 - 2030
8.2.2. Diagnostic
Testing
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 - 2021
8.2.2.3. Market
Forecast, 2022 - 2030
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.2.3. New-born
Screening
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 - 2021
8.2.3.3. Market
Forecast, 2022 - 2030
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 - 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 - 2030
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 - 2030
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 - 2030
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 - 2030
8.2.4. Predictive
and Pre-Symptomatic Testing
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 - 2021
8.2.4.3. Market
Forecast, 2022 - 2030
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 - 2021
8.2.4.5.1.2. Market
Forecast, 2022 - 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2021
8.2.4.5.2.2. Market
Forecast, 2022 - 2030
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2021
8.2.4.5.3.2. Market
Forecast, 2022 - 2030
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2021
8.2.4.5.4.2. Market
Forecast, 2022 - 2030
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 - 2021
8.2.4.5.5.2. Market
Forecast, 2022 - 2030
8.2.5. Pharmacogenetics
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 - 2021
8.2.5.3. Market
Forecast, 2022 - 2030
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 - 2021
8.2.5.5.1.2. Market
Forecast, 2022 - 2030
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 - 2021
8.2.5.5.2.2. Market
Forecast, 2022 - 2030
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 - 2021
8.2.5.5.3.2. Market
Forecast, 2022 - 2030
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 - 2021
8.2.5.5.4.2. Market
Forecast, 2022 - 2030
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 - 2021
8.2.5.5.5.2. Market
Forecast, 2022 - 2030
8.2.6. Prenatal
Testing
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 - 2021
8.2.6.3. Market
Forecast, 2022 - 2030
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2015 - 2021
8.2.6.5.1.2. Market
Forecast, 2022 - 2030
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 - 2021
8.2.6.5.2.2. Market
Forecast, 2022 - 2030
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2015 - 2021
8.2.6.5.3.2. Market
Forecast, 2022 - 2030
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 - 2021
8.2.6.5.4.2. Market
Forecast, 2022 - 2030
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2015 - 2021
8.2.6.5.5.2. Market
Forecast, 2022 - 2030
8.2.7. Preimplantation
Testing
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 - 2021
8.2.7.3. Market
Forecast, 2022 - 2030
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 - 2021
8.2.7.5.1.2. Market
Forecast, 2022 - 2030
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 - 2021
8.2.7.5.2.2. Market
Forecast, 2022 - 2030
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 - 2021
8.2.7.5.3.2. Market
Forecast, 2022 - 2030
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 - 2021
8.2.7.5.4.2. Market
Forecast, 2022 - 2030
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 - 2021
8.2.7.5.5.2. Market
Forecast, 2022 - 2030
8.2.8. Others
8.2.8.1. Definition
8.2.8.2. Market
Estimation and Penetration, 2015 - 2021
8.2.8.3. Market
Forecast, 2022 - 2030
8.2.8.4. Compound
Annual Growth Rate (CAGR)
8.2.8.5. Regional
Bifurcation
8.2.8.5.1. North
America
8.2.8.5.1.1. Market
Estimation, 2015 - 2021
8.2.8.5.1.2. Market
Forecast, 2022 - 2030
8.2.8.5.2. Europe
8.2.8.5.2.1. Market
Estimation, 2015 - 2021
8.2.8.5.2.2. Market
Forecast, 2022 - 2030
8.2.8.5.3. Asia
Pacific
8.2.8.5.3.1. Market
Estimation, 2015 - 2021
8.2.8.5.3.2. Market
Forecast, 2022 - 2030
8.2.8.5.4. Middle
East and Africa
8.2.8.5.4.1. Market
Estimation, 2015 - 2021
8.2.8.5.4.2. Market
Forecast, 2022 - 2030
8.2.8.5.5. Latin
America
8.2.8.5.5.1. Market
Estimation, 2015 - 2021
8.2.8.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Testing Types
9. Global Genetic Testing Market Analysis and Forecasts, 2022 -
2030
9.1. Overview
9.2. Global
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
9.2.1. Blood
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2021
9.2.1.3. Market
Forecast, 2022 - 2030
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Buccal
Swab
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2021
9.2.2.3. Market
Forecast, 2022 - 2030
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Amniocentesis
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2021
9.2.3.3. Market
Forecast, 2022 - 2030
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.2.4. Chorionic
Villus Sampling
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2021
9.2.4.3. Market
Forecast, 2022 - 2030
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 - 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 - 2030
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 - 2030
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 - 2030
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 - 2030
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 - 2021
9.2.5.3. Market
Forecast, 2022 - 2030
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 - 2021
9.2.5.5.1.2. Market
Forecast, 2022 - 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2021
9.2.5.5.2.2. Market
Forecast, 2022 - 2030
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2021
9.2.5.5.3.2. Market
Forecast, 2022 - 2030
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2021
9.2.5.5.4.2. Market
Forecast, 2022 - 2030
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 - 2021
9.2.5.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Sample Type
10. Global Genetic Testing Market Analysis and Forecasts, 2022 -
2030
10.1. Overview
10.2. Global
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
10.2.1. Single
Gene Disorders
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 - 2021
10.2.1.3. Market
Forecast, 2022 - 2030
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 - 2030
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 - 2030
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 - 2030
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 - 2030
10.2.2. Cardiovascular
Diseases
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 - 2021
10.2.2.3. Market
Forecast, 2022 - 2030
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 - 2030
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 - 2030
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 - 2030
10.2.3. Cancer
Diagnosis (Definition, Market Estimation and Penetration, 2015 - 2021, Market
Estimation (2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Colon Cancer, Breast Cancer,
Ovarian Cancer, Others)
10.2.3.1. Colon
Cancer
10.2.3.2. Breast
Cancer
10.2.3.3. Ovarian
Cancer
10.2.3.4. Others
10.2.4. Ophthalmology
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 - 2021
10.2.4.3. Market
Forecast, 2022 - 2030
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 - 2030
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 - 2030
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 - 2030
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 - 2030
10.2.5. Dermatology
10.2.5.1. Definition
10.2.5.2. Market
Estimation and Penetration, 2015 - 2021
10.2.5.3. Market
Forecast, 2022 - 2030
10.2.5.4. Compound
Annual Growth Rate (CAGR)
10.2.5.5. Regional
Bifurcation
10.2.5.5.1. North
America
10.2.5.5.1.1. Market
Estimation, 2015 - 2021
10.2.5.5.1.2. Market
Forecast, 2022 - 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2021
10.2.5.5.2.2. Market
Forecast, 2022 - 2030
10.2.5.5.3. Asia
Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2021
10.2.5.5.3.2. Market
Forecast, 2022 - 2030
10.2.5.5.4. Middle
East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2021
10.2.5.5.4.2. Market
Forecast, 2022 - 2030
10.2.5.5.5. Latin
America
10.2.5.5.5.1. Market
Estimation, 2015 - 2021
10.2.5.5.5.2. Market
Forecast, 2022 - 2030
10.2.6. Neurology
10.2.6.1. Definition
10.2.6.2. Market
Estimation and Penetration, 2015 - 2021
10.2.6.3. Market
Forecast, 2022 - 2030
10.2.6.4. Compound
Annual Growth Rate (CAGR)
10.2.6.5. Regional
Bifurcation
10.2.6.5.1. North
America
10.2.6.5.1.1. Market
Estimation, 2015 - 2021
10.2.6.5.1.2. Market
Forecast, 2022 - 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 - 2021
10.2.6.5.2.2. Market
Forecast, 2022 - 2030
10.2.6.5.3. Asia
Pacific
10.2.6.5.3.1. Market
Estimation, 2015 - 2021
10.2.6.5.3.2. Market
Forecast, 2022 - 2030
10.2.6.5.4. Middle
East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 - 2021
10.2.6.5.4.2. Market
Forecast, 2022 - 2030
10.2.6.5.5. Latin
America
10.2.6.5.5.1. Market
Estimation, 2015 - 2021
10.2.6.5.5.2. Market
Forecast, 2022 - 2030
10.2.7. Immunology
10.2.7.1. Definition
10.2.7.2. Market
Estimation and Penetration, 2015 - 2021
10.2.7.3. Market
Forecast, 2022 - 2030
10.2.7.4. Compound
Annual Growth Rate (CAGR)
10.2.7.5. Regional
Bifurcation
10.2.7.5.1. North
America
10.2.7.5.1.1. Market
Estimation, 2015 - 2021
10.2.7.5.1.2. Market
Forecast, 2022 - 2030
10.2.7.5.2. Europe
10.2.7.5.2.1. Market
Estimation, 2015 - 2021
10.2.7.5.2.2. Market
Forecast, 2022 - 2030
10.2.7.5.3. Asia
Pacific
10.2.7.5.3.1. Market
Estimation, 2015 - 2021
10.2.7.5.3.2. Market
Forecast, 2022 - 2030
10.2.7.5.4. Middle
East and Africa
10.2.7.5.4.1. Market
Estimation, 2015 - 2021
10.2.7.5.4.2. Market
Forecast, 2022 - 2030
10.2.7.5.5. Latin
America
10.2.7.5.5.1. Market
Estimation, 2015 - 2021
10.2.7.5.5.2. Market
Forecast, 2022 - 2030
10.2.8. Hematology
10.2.8.1. Definition
10.2.8.2. Market
Estimation and Penetration, 2015 - 2021
10.2.8.3. Market
Forecast, 2022 - 2030
10.2.8.4. Compound
Annual Growth Rate (CAGR)
10.2.8.5. Regional
Bifurcation
10.2.8.5.1. North
America
10.2.8.5.1.1. Market
Estimation, 2015 - 2021
10.2.8.5.1.2. Market
Forecast, 2022 - 2030
10.2.8.5.2. Europe
10.2.8.5.2.1. Market
Estimation, 2015 - 2021
10.2.8.5.2.2. Market
Forecast, 2022 - 2030
10.2.8.5.3. Asia
Pacific
10.2.8.5.3.1. Market
Estimation, 2015 - 2021
10.2.8.5.3.2. Market
Forecast, 2022 - 2030
10.2.8.5.4. Middle
East and Africa
10.2.8.5.4.1. Market
Estimation, 2015 - 2021
10.2.8.5.4.2. Market
Forecast, 2022 - 2030
10.2.8.5.5. Latin
America
10.2.8.5.5.1. Market
Estimation, 2015 - 2021
10.2.8.5.5.2. Market
Forecast, 2022 - 2030
10.2.9. Pediatric
Genetics
10.2.9.1. Definition
10.2.9.2. Market
Estimation and Penetration, 2015 - 2021
10.2.9.3. Market
Forecast, 2022 - 2030
10.2.9.4. Compound
Annual Growth Rate (CAGR)
10.2.9.5. Regional
Bifurcation
10.2.9.5.1. North
America
10.2.9.5.1.1. Market
Estimation, 2015 - 2021
10.2.9.5.1.2. Market
Forecast, 2022 - 2030
10.2.9.5.2. Europe
10.2.9.5.2.1. Market
Estimation, 2015 - 2021
10.2.9.5.2.2. Market
Forecast, 2022 - 2030
10.2.9.5.3. Asia
Pacific
10.2.9.5.3.1. Market
Estimation, 2015 - 2021
10.2.9.5.3.2. Market
Forecast, 2022 - 2030
10.2.9.5.4. Middle
East and Africa
10.2.9.5.4.1. Market
Estimation, 2015 - 2021
10.2.9.5.4.2. Market
Forecast, 2022 - 2030
10.2.9.5.5. Latin
America
10.2.9.5.5.1. Market
Estimation, 2015 - 2021
10.2.9.5.5.2. Market
Forecast, 2022 - 2030
10.2.10. Metabolic
disorders
10.2.10.1. Definition
10.2.10.2. Market
Estimation and Penetration, 2015 - 2021
10.2.10.3. Market
Forecast, 2022 - 2030
10.2.10.4. Compound
Annual Growth Rate (CAGR)
10.2.10.5. Regional
Bifurcation
10.2.10.5.1. North
America
10.2.10.5.1.1. Market
Estimation, 2015 - 2021
10.2.10.5.1.2. Market
Forecast, 2022 - 2030
10.2.10.5.2. Europe
10.2.10.5.2.1. Market
Estimation, 2015 - 2021
10.2.10.5.2.2. Market
Forecast, 2022 - 2030
10.2.10.5.3. Asia
Pacific
10.2.10.5.3.1. Market
Estimation, 2015 - 2021
10.2.10.5.3.2. Market
Forecast, 2022 - 2030
10.2.10.5.4. Middle
East and Africa
10.2.10.5.4.1. Market
Estimation, 2015 - 2021
10.2.10.5.4.2. Market
Forecast, 2022 - 2030
10.2.10.5.5. Latin
America
10.2.10.5.5.1. Market
Estimation, 2015 - 2021
10.2.10.5.5.2. Market
Forecast, 2022 - 2030
10.2.11. Others
10.2.11.1. Definition
10.2.11.2. Market
Estimation and Penetration, 2015 - 2021
10.2.11.3. Market
Forecast, 2022 - 2030
10.2.11.4. Compound
Annual Growth Rate (CAGR)
10.2.11.5. Regional
Bifurcation
10.2.11.5.1. North
America
10.2.11.5.1.1. Market
Estimation, 2015 - 2021
10.2.11.5.1.2. Market
Forecast, 2022 - 2030
10.2.11.5.2. Europe
10.2.11.5.2.1. Market
Estimation, 2015 - 2021
10.2.11.5.2.2. Market
Forecast, 2022 - 2030
10.2.11.5.3. Asia
Pacific
10.2.11.5.3.1. Market
Estimation, 2015 - 2021
10.2.11.5.3.2. Market
Forecast, 2022 - 2030
10.2.11.5.4. Middle
East and Africa
10.2.11.5.4.1. Market
Estimation, 2015 - 2021
10.2.11.5.4.2. Market
Forecast, 2022 - 2030
10.2.11.5.5. Latin
America
10.2.11.5.5.1. Market
Estimation, 2015 - 2021
10.2.11.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By Indication
11. Global Genetic Testing Market Analysis and Forecasts, 2022 -
2030
11.1. Overview
11.2. Global
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
11.2.1. Hospital
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 - 2021
11.2.1.3. Market
Forecast, 2022 - 2030
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 - 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 - 2030
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 - 2030
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 - 2030
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 - 2030
11.2.2. Specialty
Clinics
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 - 2021
11.2.2.3. Market
Forecast, 2022 - 2030
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 - 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 - 2030
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 - 2030
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 - 2030
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 - 2030
11.2.3. Diagnostic
Centers
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 - 2021
11.2.3.3. Market
Forecast, 2022 - 2030
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 - 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 - 2030
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 - 2030
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 - 2030
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 - 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By
Providers
12. North America Genetic Testing Market Analysis and Forecasts, 2022
- 2030
12.1. Overview
12.1.1. North
America Genetic Testing Market Revenue (US$ Mn)
12.2. North
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
12.2.1. Carrier
Testing
12.2.2. Diagnostic
Testing
12.2.3. New-born
Screening
12.2.4. Predictive
and Pre-Symptomatic Testing
12.2.5. Pharmacogenetics
12.2.6. Prenatal
Testing
12.2.7. Preimplantation
Testing
12.2.8. Others
12.3. North
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
12.3.1. Blood
12.3.2. Buccal
Swab
12.3.3. Amniocentesis
12.3.4. Chorionic
Villus Sampling
12.3.5. Others
12.4. North
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
12.4.1. Single
Gene Disorders
12.4.2. Cardiovascular
Diseases
12.4.3. Cancer
Diagnosis
12.4.3.1. Colon
Cancer
12.4.3.2. Breast
Cancer
12.4.3.3. Ovarian
Cancer
12.4.3.4. Others
12.4.4. Ophthalmology
12.4.5. Dermatology
12.4.6. Neurology
12.4.7. Immunology
12.4.8. Hematology
12.4.9. Pediatric
Genetics
12.4.10. Metabolic
disorders
12.4.11. Others
12.5. North
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
12.5.1. Hospital
12.5.2. Specialty
Clinics
12.5.3. Diagnostic
Centers
12.6. North
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
12.6.1.1.1. Carrier
Testing
12.6.1.1.2. Diagnostic
Testing
12.6.1.1.3. New-born
Screening
12.6.1.1.4. Predictive
and Pre-Symptomatic Testing
12.6.1.1.5. Pharmacogenetics
12.6.1.1.6. Prenatal
Testing
12.6.1.1.7. Preimplantation
Testing
12.6.1.1.8. Others
12.6.1.2. U.S
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
12.6.1.2.1. Blood
12.6.1.2.2. Buccal
Swab
12.6.1.2.3. Amniocentesis
12.6.1.2.4. Chorionic
Villus Sampling
12.6.1.2.5. Others
12.6.1.3. U.S
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
12.6.1.3.1. Single
Gene Disorders
12.6.1.3.2. Cardiovascular
Diseases
12.6.1.3.3. Cancer
Diagnosis
12.6.1.3.3.1. Colon
Cancer
12.6.1.3.3.2. Breast
Cancer
12.6.1.3.3.3. Ovarian
Cancer
12.6.1.3.3.4. Others
12.6.1.3.4. Ophthalmology
12.6.1.3.5. Dermatology
12.6.1.3.6. Neurology
12.6.1.3.7. Immunology
12.6.1.3.8. Hematology
12.6.1.3.9. Pediatric
Genetics
12.6.1.3.10. Metabolic
disorders
12.6.1.3.11. Others
12.6.1.4. U.S
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
12.6.1.4.1. Hospital
12.6.1.4.2. Specialty
Clinics
12.6.1.4.3. Diagnostic
Centers
12.6.2. Canada
12.6.2.1. Canada
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
12.6.2.1.1. Carrier
Testing
12.6.2.1.2. Diagnostic
Testing
12.6.2.1.3. New-born
Screening
12.6.2.1.4. Predictive
and Pre-Symptomatic Testing
12.6.2.1.5. Pharmacogenetics
12.6.2.1.6. Prenatal
Testing
12.6.2.1.7. Preimplantation
Testing
12.6.2.1.8. Others
12.6.2.2. Canada
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
12.6.2.2.1. Blood
12.6.2.2.2. Buccal
Swab
12.6.2.2.3. Amniocentesis
12.6.2.2.4. Chorionic
Villus Sampling
12.6.2.2.5. Others
12.6.2.3. Canada
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
12.6.2.3.1. Single
Gene Disorders
12.6.2.3.2. Cardiovascular
Diseases
12.6.2.3.3. Cancer
Diagnosis
12.6.2.3.3.1. Colon
Cancer
12.6.2.3.3.2. Breast
Cancer
12.6.2.3.3.3. Ovarian
Cancer
12.6.2.3.3.4. Others
12.6.2.3.4. Ophthalmology
12.6.2.3.5. Dermatology
12.6.2.3.6. Neurology
12.6.2.3.7. Immunology
12.6.2.3.8. Hematology
12.6.2.3.9. Pediatric
Genetics
12.6.2.3.10. Metabolic
disorders
12.6.2.3.11. Others
12.6.2.4. Canada
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
12.6.2.4.1. Hospital
12.6.2.4.2. Specialty
Clinics
12.6.2.4.3. Diagnostic
Centers
12.6.3. Mexico
12.6.3.1. Mexico
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
12.6.3.1.1. Carrier
Testing
12.6.3.1.2. Diagnostic
Testing
12.6.3.1.3. New-born
Screening
12.6.3.1.4. Predictive
and Pre-Symptomatic Testing
12.6.3.1.5. Pharmacogenetics
12.6.3.1.6. Prenatal
Testing
12.6.3.1.7. Preimplantation
Testing
12.6.3.1.8. Others
12.6.3.2. Mexico
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
12.6.3.2.1. Blood
12.6.3.2.2. Buccal
Swab
12.6.3.2.3. Amniocentesis
12.6.3.2.4. Chorionic
Villus Sampling
12.6.3.2.5. Others
12.6.3.3. Mexico
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
12.6.3.3.1. Single
Gene Disorders
12.6.3.3.2. Cardiovascular
Diseases
12.6.3.3.3. Cancer
Diagnosis
12.6.3.3.3.1. Colon
Cancer
12.6.3.3.3.2. Breast
Cancer
12.6.3.3.3.3. Ovarian
Cancer
12.6.3.3.3.4. Others
12.6.3.3.4. Ophthalmology
12.6.3.3.5. Dermatology
12.6.3.3.6. Neurology
12.6.3.3.7. Immunology
12.6.3.3.8. Hematology
12.6.3.3.9. Pediatric
Genetics
12.6.3.3.10. Metabolic
disorders
12.6.3.3.11. Others
12.6.3.4. Mexico
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
12.6.3.4.1. Hospital
12.6.3.4.2. Specialty
Clinics
12.6.3.4.3. Diagnostic
Centers
12.6.4. Rest of
North America
12.6.4.1. Rest
of North America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Testing Types
12.6.4.1.1. Carrier
Testing
12.6.4.1.2. Diagnostic
Testing
12.6.4.1.3. New-born
Screening
12.6.4.1.4. Predictive
and Pre-Symptomatic Testing
12.6.4.1.5. Pharmacogenetics
12.6.4.1.6. Prenatal
Testing
12.6.4.1.7. Preimplantation
Testing
12.6.4.1.8. Others
12.6.4.2. Rest
of North America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Sample Type
12.6.4.2.1. Blood
12.6.4.2.2. Buccal
Swab
12.6.4.2.3. Amniocentesis
12.6.4.2.4. Chorionic
Villus Sampling
12.6.4.2.5. Others
12.6.4.3. Rest
of North America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
12.6.4.3.1. Single
Gene Disorders
12.6.4.3.2. Cardiovascular
Diseases
12.6.4.3.3. Cancer
Diagnosis
12.6.4.3.3.1. Colon
Cancer
12.6.4.3.3.2. Breast
Cancer
12.6.4.3.3.3. Ovarian
Cancer
12.6.4.3.3.4. Others
12.6.4.3.4. Ophthalmology
12.6.4.3.5. Dermatology
12.6.4.3.6. Neurology
12.6.4.3.7. Immunology
12.6.4.3.8. Hematology
12.6.4.3.9. Pediatric
Genetics
12.6.4.3.10. Metabolic
disorders
12.6.4.3.11. Others
12.6.4.4. Rest
of North America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Providers
12.6.4.4.1. Hospital
12.6.4.4.2. Specialty
Clinics
12.6.4.4.3. Diagnostic
Centers
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Testing Types
12.7.3. By
Sample Type
12.7.4. By Indication
12.7.5. By
Providers
13. Europe Genetic Testing Market Analysis and Forecasts, 2022 -
2030
13.1. Overview
13.1.1. Europe
Genetic Testing Market Revenue (US$ Mn)
13.2. Europe
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
13.2.1. Carrier
Testing
13.2.2. Diagnostic
Testing
13.2.3. New-born
Screening
13.2.4. Predictive
and Pre-Symptomatic Testing
13.2.5. Pharmacogenetics
13.2.6. Prenatal
Testing
13.2.7. Preimplantation
Testing
13.2.8. Others
13.3. Europe
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.3.1. Blood
13.3.2. Buccal
Swab
13.3.3. Amniocentesis
13.3.4. Chorionic
Villus Sampling
13.3.5. Others
13.4. Europe
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.4.1. Single
Gene Disorders
13.4.2. Cardiovascular
Diseases
13.4.3. Cancer
Diagnosis
13.4.3.1. Colon
Cancer
13.4.3.2. Breast
Cancer
13.4.3.3. Ovarian
Cancer
13.4.3.4. Others
13.4.4. Ophthalmology
13.4.5. Dermatology
13.4.6. Neurology
13.4.7. Immunology
13.4.8. Hematology
13.4.9. Pediatric
Genetics
13.4.10. Metabolic
disorders
13.4.11. Others
13.5. Europe
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.5.1. Hospital
13.5.2. Specialty
Clinics
13.5.3. Diagnostic
Centers
13.6. Europe
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
13.6.1.1.1. Carrier
Testing
13.6.1.1.2. Diagnostic
Testing
13.6.1.1.3. New-born
Screening
13.6.1.1.4. Predictive
and Pre-Symptomatic Testing
13.6.1.1.5. Pharmacogenetics
13.6.1.1.6. Prenatal
Testing
13.6.1.1.7. Preimplantation
Testing
13.6.1.1.8. Others
13.6.1.2. France
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.1.2.1. Blood
13.6.1.2.2. Buccal
Swab
13.6.1.2.3. Amniocentesis
13.6.1.2.4. Chorionic
Villus Sampling
13.6.1.2.5. Others
13.6.1.3. France
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.1.3.1. Single
Gene Disorders
13.6.1.3.2. Cardiovascular
Diseases
13.6.1.3.3. Cancer
Diagnosis
13.6.1.3.3.1. Colon
Cancer
13.6.1.3.3.2. Breast
Cancer
13.6.1.3.3.3. Ovarian
Cancer
13.6.1.3.3.4. Others
13.6.1.3.4. Ophthalmology
13.6.1.3.5. Dermatology
13.6.1.3.6. Neurology
13.6.1.3.7. Immunology
13.6.1.3.8. Hematology
13.6.1.3.9. Pediatric
Genetics
13.6.1.3.10. Metabolic
disorders
13.6.1.3.11. Others
13.6.1.4. France
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.1.4.1. Hospital
13.6.1.4.2. Specialty
Clinics
13.6.1.4.3. Diagnostic
Centers
13.6.2. The UK
13.6.2.1. The
UK Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
13.6.2.1.1. Carrier
Testing
13.6.2.1.2. Diagnostic
Testing
13.6.2.1.3. New-born
Screening
13.6.2.1.4. Predictive
and Pre-Symptomatic Testing
13.6.2.1.5. Pharmacogenetics
13.6.2.1.6. Prenatal
Testing
13.6.2.1.7. Preimplantation
Testing
13.6.2.1.8. Others
13.6.2.2. The
UK Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.2.2.1. Blood
13.6.2.2.2. Buccal
Swab
13.6.2.2.3. Amniocentesis
13.6.2.2.4. Chorionic
Villus Sampling
13.6.2.2.5. Others
13.6.2.3. The
UK Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.2.3.1. Single
Gene Disorders
13.6.2.3.2. Cardiovascular
Diseases
13.6.2.3.3. Cancer
Diagnosis
13.6.2.3.3.1. Colon
Cancer
13.6.2.3.3.2. Breast
Cancer
13.6.2.3.3.3. Ovarian
Cancer
13.6.2.3.3.4. Others
13.6.2.3.4. Ophthalmology
13.6.2.3.5. Dermatology
13.6.2.3.6. Neurology
13.6.2.3.7. Immunology
13.6.2.3.8. Hematology
13.6.2.3.9. Pediatric
Genetics
13.6.2.3.10. Metabolic
disorders
13.6.2.3.11. Others
13.6.2.4. The
UK Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.2.4.1. Hospital
13.6.2.4.2. Specialty
Clinics
13.6.2.4.3. Diagnostic
Centers
13.6.3. Spain
13.6.3.1. Spain
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
13.6.3.1.1. Carrier
Testing
13.6.3.1.2. Diagnostic
Testing
13.6.3.1.3. New-born
Screening
13.6.3.1.4. Predictive
and Pre-Symptomatic Testing
13.6.3.1.5. Pharmacogenetics
13.6.3.1.6. Prenatal
Testing
13.6.3.1.7. Preimplantation
Testing
13.6.3.1.8. Others
13.6.3.2. Spain
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.3.2.1. Blood
13.6.3.2.2. Buccal
Swab
13.6.3.2.3. Amniocentesis
13.6.3.2.4. Chorionic
Villus Sampling
13.6.3.2.5. Others
13.6.3.3. Spain
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.3.3.1. Single
Gene Disorders
13.6.3.3.2. Cardiovascular
Diseases
13.6.3.3.3. Cancer
Diagnosis
13.6.3.3.3.1. Colon
Cancer
13.6.3.3.3.2. Breast
Cancer
13.6.3.3.3.3. Ovarian
Cancer
13.6.3.3.3.4. Others
13.6.3.3.4. Ophthalmology
13.6.3.3.5. Dermatology
13.6.3.3.6. Neurology
13.6.3.3.7. Immunology
13.6.3.3.8. Hematology
13.6.3.3.9. Pediatric
Genetics
13.6.3.3.10. Metabolic
disorders
13.6.3.3.11. Others
13.6.3.4. Spain
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.3.4.1. Hospital
13.6.3.4.2. Specialty
Clinics
13.6.3.4.3. Diagnostic
Centers
13.6.4. Germany
13.6.4.1. Germany
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
13.6.4.1.1. Carrier
Testing
13.6.4.1.2. Diagnostic
Testing
13.6.4.1.3. New-born
Screening
13.6.4.1.4. Predictive
and Pre-Symptomatic Testing
13.6.4.1.5. Pharmacogenetics
13.6.4.1.6. Prenatal
Testing
13.6.4.1.7. Preimplantation
Testing
13.6.4.1.8. Others
13.6.4.2. Germany
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.4.2.1. Blood
13.6.4.2.2. Buccal
Swab
13.6.4.2.3. Amniocentesis
13.6.4.2.4. Chorionic
Villus Sampling
13.6.4.2.5. Others
13.6.4.3. Germany
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.4.3.1. Single
Gene Disorders
13.6.4.3.2. Cardiovascular
Diseases
13.6.4.3.3. Cancer
Diagnosis
13.6.4.3.3.1. Colon
Cancer
13.6.4.3.3.2. Breast
Cancer
13.6.4.3.3.3. Ovarian
Cancer
13.6.4.3.3.4. Others
13.6.4.3.4. Ophthalmology
13.6.4.3.5. Dermatology
13.6.4.3.6. Neurology
13.6.4.3.7. Immunology
13.6.4.3.8. Hematology
13.6.4.3.9. Pediatric
Genetics
13.6.4.3.10. Metabolic
disorders
13.6.4.3.11. Others
13.6.4.4. Germany
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.4.4.1. Hospital
13.6.4.4.2. Specialty
Clinics
13.6.4.4.3. Diagnostic
Centers
13.6.5. Italy
13.6.5.1. Italy
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
13.6.5.1.1. Carrier
Testing
13.6.5.1.2. Diagnostic
Testing
13.6.5.1.3. New-born
Screening
13.6.5.1.4. Predictive
and Pre-Symptomatic Testing
13.6.5.1.5. Pharmacogenetics
13.6.5.1.6. Prenatal
Testing
13.6.5.1.7. Preimplantation
Testing
13.6.5.1.8. Others
13.6.5.2. Italy
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.5.2.1. Blood
13.6.5.2.2. Buccal
Swab
13.6.5.2.3. Amniocentesis
13.6.5.2.4. Chorionic
Villus Sampling
13.6.5.2.5. Others
13.6.5.3. Italy
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.5.3.1. Single
Gene Disorders
13.6.5.3.2. Cardiovascular
Diseases
13.6.5.3.3. Cancer
Diagnosis
13.6.5.3.3.1. Colon
Cancer
13.6.5.3.3.2. Breast
Cancer
13.6.5.3.3.3. Ovarian
Cancer
13.6.5.3.3.4. Others
13.6.5.3.4. Ophthalmology
13.6.5.3.5. Dermatology
13.6.5.3.6. Neurology
13.6.5.3.7. Immunology
13.6.5.3.8. Hematology
13.6.5.3.9. Pediatric
Genetics
13.6.5.3.10. Metabolic
disorders
13.6.5.3.11. Others
13.6.5.4. Italy
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.5.4.1. Hospital
13.6.5.4.2. Specialty
Clinics
13.6.5.4.3. Diagnostic
Centers
13.6.6. Nordic
Countries
13.6.6.1. Nordic
Countries Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing
Types
13.6.6.1.1. Carrier
Testing
13.6.6.1.2. Diagnostic
Testing
13.6.6.1.3. New-born
Screening
13.6.6.1.4. Predictive
and Pre-Symptomatic Testing
13.6.6.1.5. Pharmacogenetics
13.6.6.1.6. Prenatal
Testing
13.6.6.1.7. Preimplantation
Testing
13.6.6.1.8. Others
13.6.6.2. Nordic
Countries Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.6.2.1. Blood
13.6.6.2.2. Buccal
Swab
13.6.6.2.3. Amniocentesis
13.6.6.2.4. Chorionic
Villus Sampling
13.6.6.2.5. Others
13.6.6.3. Nordic
Countries Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.6.3.1. Single
Gene Disorders
13.6.6.3.2. Cardiovascular
Diseases
13.6.6.3.3. Cancer
Diagnosis
13.6.6.3.3.1. Colon
Cancer
13.6.6.3.3.2. Breast
Cancer
13.6.6.3.3.3. Ovarian
Cancer
13.6.6.3.3.4. Others
13.6.6.3.4. Ophthalmology
13.6.6.3.5. Dermatology
13.6.6.3.6. Neurology
13.6.6.3.7. Immunology
13.6.6.3.8. Hematology
13.6.6.3.9. Pediatric
Genetics
13.6.6.3.10. Metabolic
disorders
13.6.6.3.11. Others
13.6.6.4. Nordic
Countries Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.6.4.1. Hospital
13.6.6.4.2. Specialty
Clinics
13.6.6.4.3. Diagnostic
Centers
13.6.6.5. Nordic
Countries Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux
Union Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
13.6.7.1.1. Carrier
Testing
13.6.7.1.2. Diagnostic
Testing
13.6.7.1.3. New-born
Screening
13.6.7.1.4. Predictive
and Pre-Symptomatic Testing
13.6.7.1.5. Pharmacogenetics
13.6.7.1.6. Prenatal
Testing
13.6.7.1.7. Preimplantation
Testing
13.6.7.1.8. Others
13.6.7.2. Benelux
Union Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.7.2.1. Blood
13.6.7.2.2. Buccal
Swab
13.6.7.2.3. Amniocentesis
13.6.7.2.4. Chorionic
Villus Sampling
13.6.7.2.5. Others
13.6.7.3. Benelux
Union Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.7.3.1. Single
Gene Disorders
13.6.7.3.2. Cardiovascular
Diseases
13.6.7.3.3. Cancer
Diagnosis
13.6.7.3.3.1. Colon
Cancer
13.6.7.3.3.2. Breast
Cancer
13.6.7.3.3.3. Ovarian
Cancer
13.6.7.3.3.4. Others
13.6.7.3.4. Ophthalmology
13.6.7.3.5. Dermatology
13.6.7.3.6. Neurology
13.6.7.3.7. Immunology
13.6.7.3.8. Hematology
13.6.7.3.9. Pediatric
Genetics
13.6.7.3.10. Metabolic
disorders
13.6.7.3.11. Others
13.6.7.4. Benelux
Union Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.7.4.1. Hospital
13.6.7.4.2. Specialty
Clinics
13.6.7.4.3. Diagnostic
Centers
13.6.7.5. Benelux
Union Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The
Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest
of Europe Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing
Types
13.6.8.1.1. Carrier
Testing
13.6.8.1.2. Diagnostic
Testing
13.6.8.1.3. New-born
Screening
13.6.8.1.4. Predictive
and Pre-Symptomatic Testing
13.6.8.1.5. Pharmacogenetics
13.6.8.1.6. Prenatal
Testing
13.6.8.1.7. Preimplantation
Testing
13.6.8.1.8. Others
13.6.8.2. Rest
of Europe Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
13.6.8.2.1. Blood
13.6.8.2.2. Buccal
Swab
13.6.8.2.3. Amniocentesis
13.6.8.2.4. Chorionic
Villus Sampling
13.6.8.2.5. Others
13.6.8.3. Rest
of Europe Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
13.6.8.3.1. Single
Gene Disorders
13.6.8.3.2. Cardiovascular
Diseases
13.6.8.3.3. Cancer
Diagnosis
13.6.8.3.3.1. Colon
Cancer
13.6.8.3.3.2. Breast
Cancer
13.6.8.3.3.3. Ovarian
Cancer
13.6.8.3.3.4. Others
13.6.8.3.4. Ophthalmology
13.6.8.3.5. Dermatology
13.6.8.3.6. Neurology
13.6.8.3.7. Immunology
13.6.8.3.8. Hematology
13.6.8.3.9. Pediatric
Genetics
13.6.8.3.10. Metabolic
disorders
13.6.8.3.11. Others
13.6.8.4. Rest
of Europe Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
13.6.8.4.1. Hospital
13.6.8.4.2. Specialty
Clinics
13.6.8.4.3. Diagnostic
Centers
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Testing Types
13.7.3. By
Sample Type
13.7.4. By Indication
13.7.5. By
Providers
14. Asia Pacific Genetic Testing Market Analysis and Forecasts, 2022
- 2030
14.1. Overview
14.1.1. Asia
Pacific Genetic Testing Market Revenue (US$ Mn)
14.2. Asia
Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.2.1. Carrier
Testing
14.2.2. Diagnostic
Testing
14.2.3. New-born
Screening
14.2.4. Predictive
and Pre-Symptomatic Testing
14.2.5. Pharmacogenetics
14.2.6. Prenatal
Testing
14.2.7. Preimplantation
Testing
14.2.8. Others
14.3. Asia
Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.3.1. Blood
14.3.2. Buccal
Swab
14.3.3. Amniocentesis
14.3.4. Chorionic
Villus Sampling
14.3.5. Others
14.4. Asia
Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.4.1. Single
Gene Disorders
14.4.2. Cardiovascular
Diseases
14.4.3. Cancer
Diagnosis
14.4.3.1. Colon
Cancer
14.4.3.2. Breast
Cancer
14.4.3.3. Ovarian
Cancer
14.4.3.4. Others
14.4.4. Ophthalmology
14.4.5. Dermatology
14.4.6. Neurology
14.4.7. Immunology
14.4.8. Hematology
14.4.9. Pediatric
Genetics
14.4.10. Metabolic
disorders
14.4.11. Others
14.5. Asia
Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.5.1. Hospital
14.5.2. Specialty
Clinics
14.5.3. Diagnostic
Centers
14.6. Asia
Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.6.1.1.1. Carrier
Testing
14.6.1.1.2. Diagnostic
Testing
14.6.1.1.3. New-born
Screening
14.6.1.1.4. Predictive
and Pre-Symptomatic Testing
14.6.1.1.5. Pharmacogenetics
14.6.1.1.6. Prenatal
Testing
14.6.1.1.7. Preimplantation
Testing
14.6.1.1.8. Others
14.6.1.2. China
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.6.1.2.1. Blood
14.6.1.2.2. Buccal
Swab
14.6.1.2.3. Amniocentesis
14.6.1.2.4. Chorionic
Villus Sampling
14.6.1.2.5. Others
14.6.1.3. China
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.1.3.1. Single
Gene Disorders
14.6.1.3.2. Cardiovascular
Diseases
14.6.1.3.3. Cancer
Diagnosis
14.6.1.3.3.1. Colon
Cancer
14.6.1.3.3.2. Breast
Cancer
14.6.1.3.3.3. Ovarian
Cancer
14.6.1.3.3.4. Others
14.6.1.3.4. Ophthalmology
14.6.1.3.5. Dermatology
14.6.1.3.6. Neurology
14.6.1.3.7. Immunology
14.6.1.3.8. Hematology
14.6.1.3.9. Pediatric
Genetics
14.6.1.3.10. Metabolic
disorders
14.6.1.3.11. Others
14.6.1.4. China
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.6.1.4.1. Hospital
14.6.1.4.2. Specialty
Clinics
14.6.1.4.3. Diagnostic
Centers
14.6.2. Japan
14.6.2.1. Japan
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.6.2.1.1. Carrier
Testing
14.6.2.1.2. Diagnostic
Testing
14.6.2.1.3. New-born
Screening
14.6.2.1.4. Predictive
and Pre-Symptomatic Testing
14.6.2.1.5. Pharmacogenetics
14.6.2.1.6. Prenatal
Testing
14.6.2.1.7. Preimplantation
Testing
14.6.2.1.8. Others
14.6.2.2. Japan
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.6.2.2.1. Blood
14.6.2.2.2. Buccal
Swab
14.6.2.2.3. Amniocentesis
14.6.2.2.4. Chorionic
Villus Sampling
14.6.2.2.5. Others
14.6.2.3. Japan
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.2.3.1. Single
Gene Disorders
14.6.2.3.2. Cardiovascular
Diseases
14.6.2.3.3. Cancer
Diagnosis
14.6.2.3.3.1. Colon
Cancer
14.6.2.3.3.2. Breast
Cancer
14.6.2.3.3.3. Ovarian
Cancer
14.6.2.3.3.4. Others
14.6.2.3.4. Ophthalmology
14.6.2.3.5. Dermatology
14.6.2.3.6. Neurology
14.6.2.3.7. Immunology
14.6.2.3.8. Hematology
14.6.2.3.9. Pediatric
Genetics
14.6.2.3.10. Metabolic
disorders
14.6.2.3.11. Others
14.6.2.4. Japan
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.6.2.4.1. Hospital
14.6.2.4.2. Specialty
Clinics
14.6.2.4.3. Diagnostic
Centers
14.6.3. India
14.6.3.1. India
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.6.3.1.1. Carrier
Testing
14.6.3.1.2. Diagnostic
Testing
14.6.3.1.3. New-born
Screening
14.6.3.1.4. Predictive
and Pre-Symptomatic Testing
14.6.3.1.5. Pharmacogenetics
14.6.3.1.6. Prenatal
Testing
14.6.3.1.7. Preimplantation
Testing
14.6.3.1.8. Others
14.6.3.2. India
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.6.3.2.1. Blood
14.6.3.2.2. Buccal
Swab
14.6.3.2.3. Amniocentesis
14.6.3.2.4. Chorionic
Villus Sampling
14.6.3.2.5. Others
14.6.3.3. India
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.3.3.1. Single
Gene Disorders
14.6.3.3.2. Cardiovascular
Diseases
14.6.3.3.3. Cancer
Diagnosis
14.6.3.3.3.1. Colon
Cancer
14.6.3.3.3.2. Breast
Cancer
14.6.3.3.3.3. Ovarian
Cancer
14.6.3.3.3.4. Others
14.6.3.3.4. Ophthalmology
14.6.3.3.5. Dermatology
14.6.3.3.6. Neurology
14.6.3.3.7. Immunology
14.6.3.3.8. Hematology
14.6.3.3.9. Pediatric
Genetics
14.6.3.3.10. Metabolic
disorders
14.6.3.3.11. Others
14.6.3.4. India
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.6.3.4.1. Hospital
14.6.3.4.2. Specialty
Clinics
14.6.3.4.3. Diagnostic
Centers
14.6.4. New
Zealand
14.6.4.1. New
Zealand Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.6.4.1.1. Carrier
Testing
14.6.4.1.2. Diagnostic
Testing
14.6.4.1.3. New-born
Screening
14.6.4.1.4. Predictive
and Pre-Symptomatic Testing
14.6.4.1.5. Pharmacogenetics
14.6.4.1.6. Prenatal
Testing
14.6.4.1.7. Preimplantation
Testing
14.6.4.1.8. Others
14.6.4.2. New
Zealand Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.6.4.2.1. Blood
14.6.4.2.2. Buccal
Swab
14.6.4.2.3. Amniocentesis
14.6.4.2.4. Chorionic
Villus Sampling
14.6.4.2.5. Others
14.6.4.3. New Zealand
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.4.3.1. Single
Gene Disorders
14.6.4.3.2. Cardiovascular
Diseases
14.6.4.3.3. Cancer
Diagnosis
14.6.4.3.3.1. Colon
Cancer
14.6.4.3.3.2. Breast
Cancer
14.6.4.3.3.3. Ovarian
Cancer
14.6.4.3.3.4. Others
14.6.4.3.4. Ophthalmology
14.6.4.3.5. Dermatology
14.6.4.3.6. Neurology
14.6.4.3.7. Immunology
14.6.4.3.8. Hematology
14.6.4.3.9. Pediatric
Genetics
14.6.4.3.10. Metabolic
disorders
14.6.4.3.11. Others
14.6.4.4. New
Zealand Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.6.4.4.1. Hospital
14.6.4.4.2. Specialty
Clinics
14.6.4.4.3. Diagnostic
Centers
14.6.5. Australia
14.6.5.1. Australia
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.6.5.1.1. Carrier
Testing
14.6.5.1.2. Diagnostic
Testing
14.6.5.1.3. New-born
Screening
14.6.5.1.4. Predictive
and Pre-Symptomatic Testing
14.6.5.1.5. Pharmacogenetics
14.6.5.1.6. Prenatal
Testing
14.6.5.1.7. Preimplantation
Testing
14.6.5.1.8. Others
14.6.5.2. Australia
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.6.5.2.1. Blood
14.6.5.2.2. Buccal
Swab
14.6.5.2.3. Amniocentesis
14.6.5.2.4. Chorionic
Villus Sampling
14.6.5.2.5. Others
14.6.5.3. Australia
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.5.3.1. Single
Gene Disorders
14.6.5.3.2. Cardiovascular
Diseases
14.6.5.3.3. Cancer
Diagnosis
14.6.5.3.3.1. Colon
Cancer
14.6.5.3.3.2. Breast
Cancer
14.6.5.3.3.3. Ovarian
Cancer
14.6.5.3.3.4. Others
14.6.5.3.4. Ophthalmology
14.6.5.3.5. Dermatology
14.6.5.3.6. Neurology
14.6.5.3.7. Immunology
14.6.5.3.8. Hematology
14.6.5.3.9. Pediatric
Genetics
14.6.5.3.10. Metabolic
disorders
14.6.5.3.11. Others
14.6.5.4. Australia
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.6.5.4.1. Hospital
14.6.5.4.2. Specialty
Clinics
14.6.5.4.3. Diagnostic
Centers
14.6.6. South
Korea
14.6.6.1. South
Korea Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.6.6.1.1. Carrier
Testing
14.6.6.1.2. Diagnostic
Testing
14.6.6.1.3. New-born
Screening
14.6.6.1.4. Predictive
and Pre-Symptomatic Testing
14.6.6.1.5. Pharmacogenetics
14.6.6.1.6. Prenatal
Testing
14.6.6.1.7. Preimplantation
Testing
14.6.6.1.8. Others
14.6.6.2. South
Korea Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.6.6.2.1. Blood
14.6.6.2.2. Buccal
Swab
14.6.6.2.3. Amniocentesis
14.6.6.2.4. Chorionic
Villus Sampling
14.6.6.2.5. Others
14.6.6.3. South
Korea Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.6.3.1. Single
Gene Disorders
14.6.6.3.2. Cardiovascular
Diseases
14.6.6.3.3. Cancer
Diagnosis
14.6.6.3.3.1. Colon
Cancer
14.6.6.3.3.2. Breast
Cancer
14.6.6.3.3.3. Ovarian
Cancer
14.6.6.3.3.4. Others
14.6.6.3.4. Ophthalmology
14.6.6.3.5. Dermatology
14.6.6.3.6. Neurology
14.6.6.3.7. Immunology
14.6.6.3.8. Hematology
14.6.6.3.9. Pediatric
Genetics
14.6.6.3.10. Metabolic
disorders
14.6.6.3.11. Others
14.6.6.4. South
Korea Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.6.6.4.1. Hospital
14.6.6.4.2. Specialty
Clinics
14.6.6.4.3. Diagnostic
Centers
14.6.7. Southeast
Asia
14.6.7.1. Southeast
Asia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
14.6.7.1.1. Carrier
Testing
14.6.7.1.2. Diagnostic
Testing
14.6.7.1.3. New-born
Screening
14.6.7.1.4. Predictive
and Pre-Symptomatic Testing
14.6.7.1.5. Pharmacogenetics
14.6.7.1.6. Prenatal
Testing
14.6.7.1.7. Preimplantation
Testing
14.6.7.1.8. Others
14.6.7.2. Southeast
Asia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.6.7.2.1. Blood
14.6.7.2.2. Buccal
Swab
14.6.7.2.3. Amniocentesis
14.6.7.2.4. Chorionic
Villus Sampling
14.6.7.2.5. Others
14.6.7.3. Southeast
Asia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.7.3.1. Single
Gene Disorders
14.6.7.3.2. Cardiovascular
Diseases
14.6.7.3.3. Cancer
Diagnosis
14.6.7.3.3.1. Colon
Cancer
14.6.7.3.3.2. Breast
Cancer
14.6.7.3.3.3. Ovarian
Cancer
14.6.7.3.3.4. Others
14.6.7.3.4. Ophthalmology
14.6.7.3.5. Dermatology
14.6.7.3.6. Neurology
14.6.7.3.7. Immunology
14.6.7.3.8. Hematology
14.6.7.3.9. Pediatric
Genetics
14.6.7.3.10. Metabolic
disorders
14.6.7.3.11. Others
14.6.7.4. Southeast
Asia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
14.6.7.4.1. Hospital
14.6.7.4.2. Specialty
Clinics
14.6.7.4.3. Diagnostic
Centers
14.6.7.5. Southeast
Asia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest
of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest
of Asia Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Testing Types
14.6.8.1.1. Carrier
Testing
14.6.8.1.2. Diagnostic
Testing
14.6.8.1.3. New-born
Screening
14.6.8.1.4. Predictive
and Pre-Symptomatic Testing
14.6.8.1.5. Pharmacogenetics
14.6.8.1.6. Prenatal
Testing
14.6.8.1.7. Preimplantation
Testing
14.6.8.1.8. Others
14.6.8.2. Rest
of Asia Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Sample Type
14.6.8.2.1. Blood
14.6.8.2.2. Buccal
Swab
14.6.8.2.3. Amniocentesis
14.6.8.2.4. Chorionic
Villus Sampling
14.6.8.2.5. Others
14.6.8.3. Rest
of Asia Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
14.6.8.3.1. Single
Gene Disorders
14.6.8.3.2. Cardiovascular
Diseases
14.6.8.3.3. Cancer
Diagnosis
14.6.8.3.3.1. Colon
Cancer
14.6.8.3.3.2. Breast
Cancer
14.6.8.3.3.3. Ovarian
Cancer
14.6.8.3.3.4. Others
14.6.8.3.4. Ophthalmology
14.6.8.3.5. Dermatology
14.6.8.3.6. Neurology
14.6.8.3.7. Immunology
14.6.8.3.8. Hematology
14.6.8.3.9. Pediatric
Genetics
14.6.8.3.10. Metabolic
disorders
14.6.8.3.11. Others
14.6.8.4. Rest
of Asia Pacific Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Providers
14.6.8.4.1. Hospital
14.6.8.4.2. Specialty
Clinics
14.6.8.4.3. Diagnostic
Centers
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Testing Types
14.7.3. By
Sample Type
14.7.4. By Indication
14.7.5. By
Providers
15. Middle East and Africa Genetic Testing Market Analysis and
Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Middle
East and Africa Genetic Testing Market Revenue (US$ Mn)
15.2. Middle
East and Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Testing Types
15.2.1. Carrier
Testing
15.2.2. Diagnostic
Testing
15.2.3. New-born
Screening
15.2.4. Predictive
and Pre-Symptomatic Testing
15.2.5. Pharmacogenetics
15.2.6. Prenatal
Testing
15.2.7. Preimplantation
Testing
15.2.8. Others
15.3. Middle
East and Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Sample Type
15.3.1. Blood
15.3.2. Buccal
Swab
15.3.3. Amniocentesis
15.3.4. Chorionic
Villus Sampling
15.3.5. Others
15.4. Middle
East and Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
15.4.1. Single
Gene Disorders
15.4.2. Cardiovascular
Diseases
15.4.3. Cancer
Diagnosis
15.4.3.1. Colon
Cancer
15.4.3.2. Breast
Cancer
15.4.3.3. Ovarian
Cancer
15.4.3.4. Others
15.4.4. Ophthalmology
15.4.5. Dermatology
15.4.6. Neurology
15.4.7. Immunology
15.4.8. Hematology
15.4.9. Pediatric
Genetics
15.4.10. Metabolic
disorders
15.4.11. Others
15.5. Middle
East and Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Providers
15.5.1. Hospital
15.5.2. Specialty
Clinics
15.5.3. Diagnostic
Centers
15.6. Middle East
and Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi
Arabia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
15.6.1.1.1. Carrier
Testing
15.6.1.1.2. Diagnostic
Testing
15.6.1.1.3. New-born
Screening
15.6.1.1.4. Predictive
and Pre-Symptomatic Testing
15.6.1.1.5. Pharmacogenetics
15.6.1.1.6. Prenatal
Testing
15.6.1.1.7. Preimplantation
Testing
15.6.1.1.8. Others
15.6.1.2. Saudi
Arabia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.6.1.2.1. Blood
15.6.1.2.2. Buccal
Swab
15.6.1.2.3. Amniocentesis
15.6.1.2.4. Chorionic
Villus Sampling
15.6.1.2.5. Others
15.6.1.3. Saudi
Arabia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
15.6.1.3.1. Single
Gene Disorders
15.6.1.3.2. Cardiovascular
Diseases
15.6.1.3.3. Cancer
Diagnosis
15.6.1.3.3.1. Colon
Cancer
15.6.1.3.3.2. Breast
Cancer
15.6.1.3.3.3. Ovarian
Cancer
15.6.1.3.3.4. Others
15.6.1.3.4. Ophthalmology
15.6.1.3.5. Dermatology
15.6.1.3.6. Neurology
15.6.1.3.7. Immunology
15.6.1.3.8. Hematology
15.6.1.3.9. Pediatric
Genetics
15.6.1.3.10. Metabolic
disorders
15.6.1.3.11. Others
15.6.1.4. Saudi
Arabia Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
15.6.1.4.1. Hospital
15.6.1.4.2. Specialty
Clinics
15.6.1.4.3. Diagnostic
Centers
15.6.2. UAE
15.6.2.1. UAE
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
15.6.2.1.1. Carrier
Testing
15.6.2.1.2. Diagnostic
Testing
15.6.2.1.3. New-born
Screening
15.6.2.1.4. Predictive
and Pre-Symptomatic Testing
15.6.2.1.5. Pharmacogenetics
15.6.2.1.6. Prenatal
Testing
15.6.2.1.7. Preimplantation
Testing
15.6.2.1.8. Others
15.6.2.2. UAE
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.6.2.2.1. Blood
15.6.2.2.2. Buccal
Swab
15.6.2.2.3. Amniocentesis
15.6.2.2.4. Chorionic
Villus Sampling
15.6.2.2.5. Others
15.6.2.3. UAE
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
15.6.2.3.1. Single
Gene Disorders
15.6.2.3.2. Cardiovascular
Diseases
15.6.2.3.3. Cancer
Diagnosis
15.6.2.3.3.1. Colon
Cancer
15.6.2.3.3.2. Breast
Cancer
15.6.2.3.3.3. Ovarian
Cancer
15.6.2.3.3.4. Others
15.6.2.3.4. Ophthalmology
15.6.2.3.5. Dermatology
15.6.2.3.6. Neurology
15.6.2.3.7. Immunology
15.6.2.3.8. Hematology
15.6.2.3.9. Pediatric
Genetics
15.6.2.3.10. Metabolic
disorders
15.6.2.3.11. Others
15.6.2.4. UAE
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
15.6.2.4.1. Hospital
15.6.2.4.2. Specialty
Clinics
15.6.2.4.3. Diagnostic
Centers
15.6.3. Egypt
15.6.3.1. Egypt
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
15.6.3.1.1. Carrier
Testing
15.6.3.1.2. Diagnostic
Testing
15.6.3.1.3. New-born
Screening
15.6.3.1.4. Predictive
and Pre-Symptomatic Testing
15.6.3.1.5. Pharmacogenetics
15.6.3.1.6. Prenatal
Testing
15.6.3.1.7. Preimplantation
Testing
15.6.3.1.8. Others
15.6.3.2. Egypt
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.6.3.2.1. Blood
15.6.3.2.2. Buccal
Swab
15.6.3.2.3. Amniocentesis
15.6.3.2.4. Chorionic
Villus Sampling
15.6.3.2.5. Others
15.6.3.3. Egypt
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
15.6.3.3.1. Single
Gene Disorders
15.6.3.3.2. Cardiovascular
Diseases
15.6.3.3.3. Cancer
Diagnosis
15.6.3.3.3.1. Colon
Cancer
15.6.3.3.3.2. Breast
Cancer
15.6.3.3.3.3. Ovarian
Cancer
15.6.3.3.3.4. Others
15.6.3.3.4. Ophthalmology
15.6.3.3.5. Dermatology
15.6.3.3.6. Neurology
15.6.3.3.7. Immunology
15.6.3.3.8. Hematology
15.6.3.3.9. Pediatric
Genetics
15.6.3.3.10. Metabolic
disorders
15.6.3.3.11. Others
15.6.3.4. Egypt
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
15.6.3.4.1. Hospital
15.6.3.4.2. Specialty
Clinics
15.6.3.4.3. Diagnostic
Centers
15.6.4. Kuwait
15.6.4.1. Kuwait
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
15.6.4.1.1. Carrier
Testing
15.6.4.1.2. Diagnostic
Testing
15.6.4.1.3. New-born
Screening
15.6.4.1.4. Predictive
and Pre-Symptomatic Testing
15.6.4.1.5. Pharmacogenetics
15.6.4.1.6. Prenatal
Testing
15.6.4.1.7. Preimplantation
Testing
15.6.4.1.8. Others
15.6.4.2. Kuwait
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.6.4.2.1. Blood
15.6.4.2.2. Buccal
Swab
15.6.4.2.3. Amniocentesis
15.6.4.2.4. Chorionic
Villus Sampling
15.6.4.2.5. Others
15.6.4.3. Kuwait
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
15.6.4.3.1. Single
Gene Disorders
15.6.4.3.2. Cardiovascular
Diseases
15.6.4.3.3. Cancer
Diagnosis
15.6.4.3.3.1. Colon
Cancer
15.6.4.3.3.2. Breast
Cancer
15.6.4.3.3.3. Ovarian
Cancer
15.6.4.3.3.4. Others
15.6.4.3.4. Ophthalmology
15.6.4.3.5. Dermatology
15.6.4.3.6. Neurology
15.6.4.3.7. Immunology
15.6.4.3.8. Hematology
15.6.4.3.9. Pediatric
Genetics
15.6.4.3.10. Metabolic
disorders
15.6.4.3.11. Others
15.6.4.4. Kuwait
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
15.6.4.4.1. Hospital
15.6.4.4.2. Specialty
Clinics
15.6.4.4.3. Diagnostic
Centers
15.6.5. South
Africa
15.6.5.1. South
Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
15.6.5.1.1. Carrier
Testing
15.6.5.1.2. Diagnostic
Testing
15.6.5.1.3. New-born
Screening
15.6.5.1.4. Predictive
and Pre-Symptomatic Testing
15.6.5.1.5. Pharmacogenetics
15.6.5.1.6. Prenatal
Testing
15.6.5.1.7. Preimplantation
Testing
15.6.5.1.8. Others
15.6.5.2. South
Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.6.5.2.1. Blood
15.6.5.2.2. Buccal
Swab
15.6.5.2.3. Amniocentesis
15.6.5.2.4. Chorionic
Villus Sampling
15.6.5.2.5. Others
15.6.5.3. South
Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
15.6.5.3.1. Single
Gene Disorders
15.6.5.3.2. Cardiovascular
Diseases
15.6.5.3.3. Cancer
Diagnosis
15.6.5.3.3.1. Colon
Cancer
15.6.5.3.3.2. Breast
Cancer
15.6.5.3.3.3. Ovarian
Cancer
15.6.5.3.3.4. Others
15.6.5.3.4. Ophthalmology
15.6.5.3.5. Dermatology
15.6.5.3.6. Neurology
15.6.5.3.7. Immunology
15.6.5.3.8. Hematology
15.6.5.3.9. Pediatric
Genetics
15.6.5.3.10. Metabolic
disorders
15.6.5.3.11. Others
15.6.5.4. South
Africa Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
15.6.5.4.1. Hospital
15.6.5.4.2. Specialty
Clinics
15.6.5.4.3. Diagnostic
Centers
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest
of Middle East & Africa Genetic Testing Market Revenue (US$ Mn) and
Forecasts, By Testing Types
15.6.6.1.1. Carrier
Testing
15.6.6.1.2. Diagnostic
Testing
15.6.6.1.3. New-born
Screening
15.6.6.1.4. Predictive
and Pre-Symptomatic Testing
15.6.6.1.5. Pharmacogenetics
15.6.6.1.6. Prenatal
Testing
15.6.6.1.7. Preimplantation
Testing
15.6.6.1.8. Others
15.6.6.2. Rest
of Middle East & Africa Genetic Testing Market Revenue (US$ Mn) and
Forecasts, By Sample Type
15.6.6.2.1. Blood
15.6.6.2.2. Buccal
Swab
15.6.6.2.3. Amniocentesis
15.6.6.2.4. Chorionic
Villus Sampling
15.6.6.2.5. Others
15.6.6.3. Rest
of Middle East & Africa Genetic Testing Market Revenue (US$ Mn) and
Forecasts, By Indication
15.6.6.3.1. Single
Gene Disorders
15.6.6.3.2. Cardiovascular
Diseases
15.6.6.3.3. Cancer
Diagnosis
15.6.6.3.3.1. Colon
Cancer
15.6.6.3.3.2. Breast
Cancer
15.6.6.3.3.3. Ovarian
Cancer
15.6.6.3.3.4. Others
15.6.6.3.4. Ophthalmology
15.6.6.3.5. Dermatology
15.6.6.3.6. Neurology
15.6.6.3.7. Immunology
15.6.6.3.8. Hematology
15.6.6.3.9. Pediatric
Genetics
15.6.6.3.10. Metabolic
disorders
15.6.6.3.11. Others
15.6.6.4. Rest
of Middle East & Africa Genetic Testing Market Revenue (US$ Mn) and
Forecasts, By Providers
15.6.6.4.1. Hospital
15.6.6.4.2. Specialty
Clinics
15.6.6.4.3. Diagnostic
Centers
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By Testing
Types
15.7.3. By
Sample Type
15.7.4. By Indication
15.7.5. By
Providers
16. Latin America Genetic Testing Market Analysis and Forecasts, 2022
- 2030
16.1. Overview
16.1.1. Latin
America Genetic Testing Market Revenue (US$ Mn)
16.2. Latin
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
16.2.1. Carrier
Testing
16.2.2. Diagnostic
Testing
16.2.3. New-born
Screening
16.2.4. Predictive
and Pre-Symptomatic Testing
16.2.5. Pharmacogenetics
16.2.6. Prenatal
Testing
16.2.7. Preimplantation
Testing
16.2.8. Others
16.3. Latin
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.3.1. Blood
16.3.2. Buccal
Swab
16.3.3. Amniocentesis
16.3.4. Chorionic
Villus Sampling
16.3.5. Others
16.4. Latin
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
16.4.1. Single
Gene Disorders
16.4.2. Cardiovascular
Diseases
16.4.3. Cancer
Diagnosis
16.4.3.1. Colon
Cancer
16.4.3.2. Breast
Cancer
16.4.3.3. Ovarian
Cancer
16.4.3.4. Others
16.4.4. Ophthalmology
16.4.5. Dermatology
16.4.6. Neurology
16.4.7. Immunology
16.4.8. Hematology
16.4.9. Pediatric
Genetics
16.4.10. Metabolic
disorders
16.4.11. Others
16.5. Latin
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
16.5.1. Hospital
16.5.2. Specialty
Clinics
16.5.3. Diagnostic
Centers
16.6. Latin
America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
16.6.1.1.1. Carrier
Testing
16.6.1.1.2. Diagnostic
Testing
16.6.1.1.3. New-born
Screening
16.6.1.1.4. Predictive
and Pre-Symptomatic Testing
16.6.1.1.5. Pharmacogenetics
16.6.1.1.6. Prenatal
Testing
16.6.1.1.7. Preimplantation
Testing
16.6.1.1.8. Others
16.6.1.2. Brazil
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.6.1.2.1. Blood
16.6.1.2.2. Buccal
Swab
16.6.1.2.3. Amniocentesis
16.6.1.2.4. Chorionic
Villus Sampling
16.6.1.2.5. Others
16.6.1.3. Brazil
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
16.6.1.3.1. Single
Gene Disorders
16.6.1.3.2. Cardiovascular
Diseases
16.6.1.3.3. Cancer
Diagnosis
16.6.1.3.3.1. Colon
Cancer
16.6.1.3.3.2. Breast
Cancer
16.6.1.3.3.3. Ovarian
Cancer
16.6.1.3.3.4. Others
16.6.1.3.4. Ophthalmology
16.6.1.3.5. Dermatology
16.6.1.3.6. Neurology
16.6.1.3.7. Immunology
16.6.1.3.8. Hematology
16.6.1.3.9. Pediatric
Genetics
16.6.1.3.10. Metabolic
disorders
16.6.1.3.11. Others
16.6.1.4. Brazil
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
16.6.1.4.1. Hospital
16.6.1.4.2. Specialty
Clinics
16.6.1.4.3. Diagnostic
Centers
16.6.2. Argentina
16.6.2.1. Argentina
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Testing Types
16.6.2.1.1. Carrier
Testing
16.6.2.1.2. Diagnostic
Testing
16.6.2.1.3. New-born
Screening
16.6.2.1.4. Predictive
and Pre-Symptomatic Testing
16.6.2.1.5. Pharmacogenetics
16.6.2.1.6. Prenatal
Testing
16.6.2.1.7. Preimplantation
Testing
16.6.2.1.8. Others
16.6.2.2. Argentina
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.6.2.2.1. Blood
16.6.2.2.2. Buccal
Swab
16.6.2.2.3. Amniocentesis
16.6.2.2.4. Chorionic
Villus Sampling
16.6.2.2.5. Others
16.6.2.3. Argentina
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
16.6.2.3.1. Single
Gene Disorders
16.6.2.3.2. Cardiovascular
Diseases
16.6.2.3.3. Cancer
Diagnosis
16.6.2.3.3.1. Colon
Cancer
16.6.2.3.3.2. Breast
Cancer
16.6.2.3.3.3. Ovarian
Cancer
16.6.2.3.3.4. Others
16.6.2.3.4. Ophthalmology
16.6.2.3.5. Dermatology
16.6.2.3.6. Neurology
16.6.2.3.7. Immunology
16.6.2.3.8. Hematology
16.6.2.3.9. Pediatric
Genetics
16.6.2.3.10. Metabolic
disorders
16.6.2.3.11. Others
16.6.2.4. Argentina
Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Providers
16.6.2.4.1. Hospital
16.6.2.4.2. Specialty
Clinics
16.6.2.4.3. Diagnostic
Centers
16.6.3. Rest of
Latin America
16.6.3.1. Rest
of Latin America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Testing Types
16.6.3.1.1. Carrier
Testing
16.6.3.1.2. Diagnostic
Testing
16.6.3.1.3. New-born
Screening
16.6.3.1.4. Predictive
and Pre-Symptomatic Testing
16.6.3.1.5. Pharmacogenetics
16.6.3.1.6. Prenatal
Testing
16.6.3.1.7. Preimplantation
Testing
16.6.3.1.8. Others
16.6.3.2. Rest
of Latin America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Sample Type
16.6.3.2.1. Blood
16.6.3.2.2. Buccal
Swab
16.6.3.2.3. Amniocentesis
16.6.3.2.4. Chorionic
Villus Sampling
16.6.3.2.5. Others
16.6.3.3. Rest
of Latin America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By Indication
16.6.3.3.1. Single
Gene Disorders
16.6.3.3.2. Cardiovascular
Diseases
16.6.3.3.3. Cancer
Diagnosis
16.6.3.3.3.1. Colon
Cancer
16.6.3.3.3.2. Breast
Cancer
16.6.3.3.3.3. Ovarian
Cancer
16.6.3.3.3.4. Others
16.6.3.3.4. Ophthalmology
16.6.3.3.5. Dermatology
16.6.3.3.6. Neurology
16.6.3.3.7. Immunology
16.6.3.3.8. Hematology
16.6.3.3.9. Pediatric
Genetics
16.6.3.3.10. Metabolic
disorders
16.6.3.3.11. Others
16.6.3.4. Rest
of Latin America Genetic Testing Market Revenue (US$ Mn) and Forecasts, By
Providers
16.6.3.4.1. Hospital
16.6.3.4.2. Specialty
Clinics
16.6.3.4.3. Diagnostic
Centers
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Testing Types
16.7.3. By
Sample Type
16.7.4. By Indication
16.7.5. By
Providers
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2021
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. Abbott
Laboratories
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Avellino
Lab USA, Inc.
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. bioMérieux
SA
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. Bio-Rad Laboratories,
Inc.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. BioReference
Laboratories
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. CENTOGENE
AG
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. EONE
LABORATORIES
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Eurofins
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. F.
Hoffmann-La Roche Ltd
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Genomic
Health
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Invitae
Corporation
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Laboratory
Corporation of America Holdings
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. MedGenome
Labs Pvt. Ltd
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business
Strategies
18.14. Myriad
Genetics, Inc
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business
Strategies
18.15. NeoGenomics
Laboratories, Inc.
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business
Strategies
18.16. QIAGEN
18.16.1. Company
Details
18.16.2. Company
Overview
18.16.3. Product
Offerings
18.16.4. Key
Developments
18.16.5. Financial
Analysis
18.16.6. SWOT
Analysis
18.16.7. Business
Strategies
18.17. Quest
Diagnostics Incorporated
18.17.1. Company
Details
18.17.2. Company
Overview
18.17.3. Product
Offerings
18.17.4. Key
Developments
18.17.5. Financial
Analysis
18.17.6. SWOT
Analysis
18.17.7. Business
Strategies
18.18. UNILABS
18.18.1. Company
Details
18.18.2. Company
Overview
18.18.3. Product
Offerings
18.18.4. Key
Developments
18.18.5. Financial
Analysis
18.18.6. SWOT
Analysis
18.18.7. Business Strategies
18.19. Other
Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
